本平台为互联网非涉密平台,严禁处理、传输国家秘密、工作秘密或敏感信息

巴氏灭活阿克曼氏菌2645菌种安全性及改善代谢综合征评价
DOI:
CSTR:
作者:
作者单位:

1.北京开景基因技术有限公司;2.湖南省直中医医院

作者简介:

通讯作者:

中图分类号:

基金项目:


Safety Evaluation and Metabolic Syndrome-Improving Effects of Pasteurized Akkermansia muciniphila 2645
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    为系统评价从中国健康儿童粪便中分离并鉴定嗜黏蛋白阿克曼氏菌AKK2645作为保健食品原料用菌株的安全性,并评估其对高脂饮食诱导小鼠代谢综合征的改善作用。本研究采用多相分类学(形态学、生理生化及16S rRNA基因测序)鉴定菌株;连续传代20代评估遗传稳定性;通过全基因组测序,进行耐药、毒力及致病基因分析;通过腹腔注射与经口灌胃进行小鼠致病性试验。在改善代谢综合征探索实验中,雄性C57BL/6J小鼠喂饲高脂饮食8周,同时每天灌胃不同剂量的巴氏灭活AKK2645,检测体重、空腹血糖、葡萄糖耐量、血清脂质及肝/脂肪组织病理变化。AKK2645鉴定为嗜黏蛋白阿克曼氏菌。传代20代后菌落形态、生化反应及16SrRNA基因序列均未改变。完整基因组中未检出耐药、毒力或致病基因。两种途径致病性试验中小鼠均无死亡、中毒或体重显著改变。高剂量巴氏灭活AKK2645(1×108 TFU/ml)使小鼠体重降低9.61%,糖耐量曲线下面积减小21.87%,血清甘油三酯和总胆固醇分别降低62.78%和41.35%;肝脏脂肪变性、腹股沟脂肪和附睾脂肪的重量分别显著降低66.67%和42.16%;棕色脂肪细胞直径显著降低60.29%。巴氏灭活AKK2645符合我国保健食品原料用菌种安全要求,且对小鼠代谢综合征具有显著改善作用,具备作为保健食品用菌种原料的转化潜力。

    Abstract:

    To isolate and identify Akkermansia muciniphila AKK2645 from the feces of healthy Chinese children, systematically evaluate the safety of pasteurized AKK2645 as a probiotic strain for use in health food raw materials, and assess its ameliorative effects on high-fat diet (HFD)- induced metabolic syndrome in mice. The strain was identified using polyphasic taxonomy (morphology, physiology, biochemistry, and 16S rRNA gene sequencing). Genetic stability was assessed over 20 consecutive passages. Whole?genome sequencing was performed to analyze resistance, virulence, and pathogenicity?related genes. Pathogenicity was evaluated in mice via intraperitoneal injection and oral gavage. For the metabolic syndrome intervention experiment, male C57BL/6J mice were fed a high?fat diet for 8 weeks, concurrently gavaged daily with different doses of pasteurized AKK2645. Body weight, fasting blood glucose, glucose tolerance, serum lipids, and histopathological changes in liver and adipose tissues were measured. AKK2645 was identified as Akkermansia muciniphila. Colony morphology, biochemical reactions, and 16S rRNA gene sequences remained unchanged after 20 passages. No resistance, virulence, or pathogenicity genes were detected in the complete genome. No mortality, toxicity, or significant changes in body weight were observed in mice during the pathogenicity test. High?dose pasteurized AKK2645 (1×10? TFU/ml) reduced body weight by 9.61%, decreased the area under the glucose tolerance curve by 21.87%, and lowered serum triglycerides and total cholesterol by 62.78% and 41.35%, respectively. Hepatic steatosis, inguinal fat weight, and epididymal fat weight were reduced by 66.67% and 42.16%, respectively; brown adipocyte diameter decreased by 60.29%. Pasteurized AKK2645 meets the safety requirements for health food raw material strains in China and exerts significant ameliorative effects on metabolic syndrome in mice, demonstrating potential for translational application as a health food ingredient strain. ???

    参考文献
    相似文献
    引证文献
引用本文
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2026-08-31
  • 最后修改日期:2026-11-16
  • 录用日期:2026-11-16
  • 在线发布日期:
  • 出版日期:
文章二维码